COVID-19: Pakistan’s Preparedness and response
DOI:
https://doi.org/10.37978/pjsm.v1i4.207Keywords:
Covid-19, Pakistan’s Preparedness, SARS-COV, MERS-COVAbstract
At the end of December 2019 in the Wuhan City of China, a novel coronavirus (Covid-19) outbreak has been proclaimed. Several cases have arisen in other cities of China. It spread simultaneously worldwide in 209 countries of Europe, Australia, America, Asia, and Pakistan. Mortality is high; millions of people have been affected while cases are rapidly increasing in the world. Different controlling strategies have been adopted for COVID-19. Pakistan took rigorous measures like the hospital, specific laboratories for testing, centres for quarantine, awareness campaign, Ehsaas Emergency Cash Programme and lockdown for controlling this virus. There is no antiviral and vaccine based treatment only preventive measures are taken.
References
Shanmugaraj B, Malla A, Phoolcharoen W. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. Pathogens. 2020;9(2):148. Available from: doi: 10.3390/pathogens9020148. PMID: 32098302; PMCID: PMC7168632. DOI: https://doi.org/10.3390/pathogens9020148
Iqbal MS, Haider S, Essa SA, Murtaza M, Maryam S, Sabir MM, Sherwani SK. Coronavirus Outbreak and Characteristics: A Mini-Review. Pak Jou MicrobioL. 2020;1(1):37-42.
Bilgin S, Kurtkulagi O, Kahveci GB, Duman TT, Tel BM. Millennium pandemic: a review of coronavirus disease (COVID-19). Exp Biomed Res. 2020;3(2):117-25. DOI: https://doi.org/10.30714/j-ebr.2020259176
Chudhary SA, Imtiaz S, Iqbal N. Laboratory Detection of Novel Corona Virus 2019 using Polymerase Chain Reaction. Int J Front Sci. 2020 Feb 1;4(2). DOI: https://doi.org/10.37978/tijfs.v4i2.5
Jiang S, Xia S, Ying T, Lu L. A novel coronavirus (2019-nCoV) causing pneumonia-associated respiratory syndrome. Cell Mol Immunol. 2020;17(5):554. Available from: doi: 10.1038/s41423-020-0372-4. Epub 2020 Feb 5. PMID: 32024976; PMCID: PMC7091741. DOI: https://doi.org/10.1038/s41423-020-0372-4
WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it [accessed 2020 May 2]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med. 1966;121(1):190-3. Available from: doi: 10.3181/00379727-121-30734. PMID: 4285768. DOI: https://doi.org/10.3181/00379727-121-30734
Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-236. Available from: doi: 10.1080/22221751.2020.1719902. Erratum in: Emerg Microbes Infect. 2020 Dec;9(1):540. PMID: 31987001; PMCID: PMC7067204. DOI: https://doi.org/10.1080/22221751.2020.1719902
Waris A, Atta UK, Ali M, Asmat A, Baset A. COVID-19 outbreak: current scenario of Pakistan. New Microbes New Infect. 2020;35:100681. Available from: doi: 10.1016/j.nmni.2020.100681. PMID: 32322403; PMCID: PMC7171524. DOI: https://doi.org/10.1016/j.nmni.2020.100681
Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020;13:8. Available from: doi: 10.1186/s40545-020-00210-w. PMID: 32328285; PMCID: PMC7168565. DOI: https://doi.org/10.1186/s40545-020-00210-w
COVID-19 [accessed on 2020 May 5]. Available from: https://www.nih.org.pk/novel-coranavirus-2019-ncov/
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Author
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Under CC-BY Liscence, you are free to
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- for any purpose, even commercially.
Please cite the author everytime you share. Thank You
